BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brockhausen I, Melamed J. Mucins as anti-cancer targets: perspectives of the glycobiologist. Glycoconj J 2021;38:459-74. [PMID: 33704667 DOI: 10.1007/s10719-021-09986-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Song Z, Zhou Y, Shen M, Zhao D, Hu H, Zeng S, Sun L, Cai S. MUC1 detection and in situ imaging method based on aptamer conformational switch and hybridization chain reaction. Talanta 2021;239:123129. [PMID: 34896820 DOI: 10.1016/j.talanta.2021.123129] [Reference Citation Analysis]
2 Barchi JJ Jr. Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates. Front Immunol 2022;13:852147. [PMID: 35432351 DOI: 10.3389/fimmu.2022.852147] [Reference Citation Analysis]
3 Du J, Zhou S, Cheng Z, Xu W, Zhang R, Wang L, Guo J. MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide. Front Chem 2022;10:814880. [DOI: 10.3389/fchem.2022.814880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Doelman W, van Kasteren SI. Synthesis of glycopeptides and glycopeptide conjugates. Org Biomol Chem 2022. [PMID: 35903971 DOI: 10.1039/d2ob00829g] [Reference Citation Analysis]
5 Mousavifar L, Roy R. Design, Synthetic Strategies, and Therapeutic Applications of Heterofunctional Glycodendrimers. Molecules 2021;26:2428. [PMID: 33921945 DOI: 10.3390/molecules26092428] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Sorieul C, Papi F, Carboni F, Pecetta S, Phogat S, Adamo R. Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics. Pharmacol Ther 2022;235:108158. [PMID: 35183590 DOI: 10.1016/j.pharmthera.2022.108158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]